Nouveautés dans la chimiothérapie du cancer colorectal métastasé

Translated title of the contribution: Developments in chemotherapy treatment of metastatic colorectal cancer

M. Ducreux, V. Boige, N. Bouarioua, B. Leconte, H. Frikha, T. Boisserie, D. Malka

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Chemotherapy of colorectal cancer has been dramatically modified during the last 10 years. Before the roles of oxaliplatin and irinotecan had been satisfactorily evaluated, targeted therapies appeared in the field of treatment for these patients. Numerous questions remain unanswered. However, recent data is helping to clarify matters concerning the day to day treatment of such patients. Clearly it is time to evaluate these recent studies and that is the aim of this article.

Translated title of the contributionDevelopments in chemotherapy treatment of metastatic colorectal cancer
Original languageFrench
Pages (from-to)169-174
Number of pages6
Issue number3
StatePublished - Mar 2008
Externally publishedYes


  • Bevacizumab
  • Cetuximab
  • Chemotherapy
  • Colorectal neoplasms
  • Irinotecan
  • Oxaliplatin
  • Panitumumab
  • Targeted therapies


Dive into the research topics of 'Developments in chemotherapy treatment of metastatic colorectal cancer'. Together they form a unique fingerprint.

Cite this